Skip to main content
. 2021 Mar 18;11:6254. doi: 10.1038/s41598-021-82602-9

Figure 6.

Figure 6

Tumor-targeting capability of IR780-NBs-DTX, IR-780 iodide and NBs(FITC) assessed via CLSM after incubation with Mia-Paca2 pancreatic cancer cells in vitro.